Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome

This is a treatment plan, and therefore patients will be monitored according to clinical
standard of care.

Inclusion Criteria:

- 6 months and older

- Diagnosis of Dravet Syndrome with intractable seizures

Exclusion Criteria:

- Hypersensitivity to the active substance or to any of the excipients

- Past history of psychoses in the form of episodes of delirium

- Impaired hepatic and/or renal function, defined as creatinine >2 and/or transaminase
>4xULN